|
Peer Reviewed 1. 342569 [Click link to view full record] Oral contraceptives for functional ovarian cysts. Obstetrics and Gynecology. 2009 Sep; 114 (3) :679-80.
| |
2.
331532 [Click link to view full record]
Futures Group International. Health Policy Initiative. Community-based distribution of injectable contraceptives. Approaches that work. Washington, D.C., Futures Group International, Health Policy Initiative, 2009 Apr. [1] p.
| |
3.
331244 [Click link to view full record]
Abell S. The morning-after pill [letter] Clinical Pediatrics. 2009 Apr; 48 (3) :341-2; discussion 342.
| |
|
Peer Reviewed 4. 341243 [Click link to view full record] Agarwal M; Das V; Agarwal A; Pandey A; Srivastava D. Evaluation of mifepristone as a once a month contraceptive pill. American Journal of Obstetrics and Gynecology. 2009 May; 200 (5) :e27-9.
| |
|
Peer Reviewed 5. 343082 [Click link to view full record] Ahrendt HJ; Makalova D; Parke S; Mellinger U; Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception. 2009 Nov; 80 (5) :436-44.
| |
6.
342617 [Click link to view full record]
Allais G; Gabellari IC; Airola G; Borgogno P; Schiapparelli P; Benedetto C. Headache induced by the use of combined oral contraceptives. Neurological Sciences. 2009 May; 30 Suppl 1 :S15-7.
| |
7.
330561 [Click link to view full record]
Allais G; Gabellari IC; De Lorenzo C; Mana O; Benedetto C. Oral contraceptives in migraine. Expert Review of Neurotherapeutics. 2009 Mar; 9 (3) :381-93.
| |
|
Peer Reviewed 8. 343179 [Click link to view full record] Allali F; El Mansouri L; Abourazzak FZ; Ichchou L; Khazzani H; Bennani L; Abouqal R; Hajjaj-Hassouni N. The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women. BMC Women's Health. 2009 Nov 3; 9 (1) :31.
| |
|
9.
341574 [Click link to view full record]
Allen K. Catching up on contraception. Australian Family Physician. 2009 Jun; 38 (6) :380-2.
| |
10.
341145 [Click link to view full record]
Alonso A; Clark CJ. Oral contraceptives and the risk of multiple sclerosis: A review of the epidemiologic evidence. Journal of the Neurological Sciences. 2009 Nov 15; 286 (1-2)
| |
11.
343107 [Click link to view full record]
Alvergne A; Lummaa V. Does the contraceptive pill alter mate choice in humans? Trends In Ecology and Evolution. 2009 Oct 2;
| |
12.
343038 [Click link to view full record]
Andreen L; Nyberg S; Turkmen S; van Wingen G; Fernandez G; Backstrom T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology. 2009 Sep; 34 (8) :1121-32.
| |
13.
331025 [Click link to view full record]
Antoniou AC; Rookus M; Andrieu N; Brohet R; Chang-Claude J. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiology, Biomarkers and Prevention. 2009 Feb; 18 (2) :601-10.
| |
|
Peer Reviewed 14. 343081 [Click link to view full record] Anttila L; Kunz M; Marr J. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Contraception. 2009 Nov; 80 (5) :445-51.
| |
15.
341751 [Click link to view full record]
Applebaum KM; Nelson HH; Zens MS; Stukel TA; Spencer SK; Karagas MR. Oral Contraceptives: A Risk Factor for Squamous Cell Carcinoma? Journal of Investigative Dermatology. 2009 Jun 25; 129 (12)
| |
16.
331499 [Click link to view full record]
Aradhya K; Lebetkin E. Hormonal methods of contraception for youth. More effective strategies are needed to improve access and encourage consistent use. Research Triangle Park, North Carolina, Family Health International [FHI], Interagency Youth Working Group, 2009 May. [4] p. (YouthLens on Reproductive Health and HIV / AIDS No. 30) |
|
Peer Reviewed 17. 342575 [Click link to view full record] Archer DF; Kovalevsky G; Ballagh SA; Grubb GS. Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen. Contraception. 2009 Sep; 80 (3) :245-53.
| |
18.
341912 [Click link to view full record]
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA; Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database of Systematic Reviews. 2009; (3) :CD004425.
| |
|
19.
343375 [Click link to view full record]
Bachmann G; Kopacz S. Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin. Patient Preference and Adherence. 2009; 3 :259-64.
| |
|
Peer Reviewed 20. 341884 [Click link to view full record] Ball H. Pill use in the month before conception linked to risk of low birth weight, preterm delivery Perspectives On Sexual and Reproductive Health. 2009 Jun; 41 (2) :128.
| |
21.
341018 [Click link to view full record]
Barden-O'Fallon J; Speizer I; Rodriguez F; Calix J. Experience with side effects among users of injectables, the IUD, and oral contraceptive pills in four urban areas of Honduras. Health Care For Women International. 2009 Jun; 30 (6) :475-83.
| |
|
Peer Reviewed 22. 341245 [Click link to view full record] Barnhart K; Mirkin S; Grubb G; Constantine G. Return to fertility after cessation of a continuous oral contraceptive. Fertility and Sterility. 2009 May; 91 (5) :1654-6.
| |
|
Peer Reviewed 23. 330562 [Click link to view full record] Barnhart KT; Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertility and Sterility. 2009 Mar; 91 (3) :659-63.
| |
|
Peer Reviewed 24. 342128 [Click link to view full record] Battaglia C; Mancini F; Fabbri R; Persico N; Busacchi P; Facchinetti F; Venturoli S. Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study. Fertility and Sterility. 2009 Jul 8;
| |
25.
330963 [Click link to view full record]
Bayle ML; Enea C; Goetinck P; Lafay F; Boisseau N; Dugue B; Flament-Waton MM; Grenier-Loustalot MF. Quantitative analysis of DHEA and androsterone in female urine: investigating the effects of menstrual cycle, oral contraception and training on exercise-induced changes in young women. Analytical and Bioanalytical Chemistry. 2009 Feb; 393 (4) :1315-25.
| |
|
Peer Reviewed 26. 330938 [Click link to view full record] Beksinska ME; Kleinschmidt I; Smit JA; Farley TM. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception. 2009 May; 79 (5) :345-9.
| |
|
Peer Reviewed 27. 342307 [Click link to view full record] Beksinska ME; Kleinschmidt I; Smit JA; Farley TM; Rees HV. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception. Contraception. 2009 Aug; 80 (2) :128-32.
| |
28.
341602 [Click link to view full record]
Belli S; Mazzola S; Luongo R; Barcella L; Alushi B. Genetic counseling for teratogenic risk due to exposure to medications: 89 pregnancies conceived during oral contraceptive use. American Journal of Medical Genetics. Part A. 2009 Jun 5; 149A (7)
| |
|
29.
343377 [Click link to view full record]
Benagiano G; Carrara S; Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Preference and Adherence. 2009; 3 :131-43.
| |
|
Peer Reviewed 30. 330467 [Click link to view full record] Berenson AB; Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. American Journal of Obstetrics and Gynecology. 2009 Mar; 200 (3) :329.e1-8.
| |
![]() |
Information & Knowledge for Optimal Health (INFO) Project 111 Market Place Suite 310, Baltimore, MD 21202 Phone: 410-659-6300 Fax: 410-659-6266 Security & Privacy Policy | ![]() |